John Newell-Price Selected Research

Osilodrostat

1/2022	Osilodrostat for the treatment of Cushing's disease: efficacy, stability, and persistence - Authors' reply.
1/2021	Approach to the Patient Treated with Steroidogenesis Inhibitors.
1/2020	Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John Newell-Price Research Topics

Disease

20	Cushing Syndrome 01/2021 - 05/2006
18	Pituitary ACTH Hypersecretion 01/2022 - 11/2007
10	Adrenal incidentaloma 01/2022 - 05/2008
8	Neoplasms (Cancer) 01/2022 - 01/2015
6	Adenoma (Adenomas) 01/2022 - 11/2015
6	Hypertension (High Blood Pressure) 01/2022 - 02/2014
4	Pituitary Neoplasms (Pituitary Adenoma) 03/2021 - 03/2012
3	Acromegaly 10/2021 - 04/2005
3	Osteoporosis 12/2018 - 06/2015
3	Carcinoid Tumor (Carcinoid) 01/2015 - 02/2006
3	Adrenal Insufficiency (Adrenal Gland Hypofunction) 03/2011 - 09/2004
2	Metabolic Bone Diseases (Osteopenia) 12/2018 - 05/2009
2	Adrenocortical Adenoma (Disease, Conn's) 12/2018 - 12/2014
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2017 - 12/2014
2	Adrenocortical Carcinoma 08/2016 - 11/2015
2	Hyperglycemia 01/2015 - 03/2012
2	Insulin Resistance 01/2013 - 01/2010
1	Hypoparathyroidism 01/2022
1	Ophthalmoplegia (External Ophthalmoplegia) 10/2021
1	Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal) 01/2021
1	ACTH-Secreting Pituitary Adenoma 01/2019
1	Hypopituitarism (Sheehan's Syndrome) 01/2019
1	Glucose Intolerance 12/2018
1	Hyperaldosteronism (Conn Syndrome) 12/2018
1	Thrombosis (Thrombus) 01/2018
1	Rare Diseases (Rare Disease) 01/2017
1	Paraganglioma (Paragangliomas) 12/2016
1	Neoplasm Metastasis (Metastasis) 08/2016
1	Type 2 Diabetes Mellitus (MODY) 08/2016
1	Pheochromocytoma 08/2016
1	Endocrine System Diseases (Endocrine Diseases) 01/2016
1	medullary Thyroid cancer 01/2016
1	Mania (Manias) 01/2016
1	Acne Vulgaris 01/2016
1	Alopecia (Baldness) 01/2016
1	Hirsutism 01/2016
1	Muscular Diseases (Myopathy) 01/2016
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2016
1	Abdominal Obesity 01/2016
1	Hyperplasia 11/2015
1	Ectopic ACTH Syndrome 11/2015
1	Obesity 06/2015
1	Nausea 01/2015
1	Fatigue 01/2015
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2015
1	Infections 12/2014
1	Infarction (Infarctions) 02/2014
1	Left Ventricular Dysfunction 02/2014
1	Heart Failure 02/2014
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 03/2011
1	Diabetes Mellitus 01/2010
1	Insulinoma 06/2008

Drug/Important Bio-Agent (IBA)

25	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2022 - 09/2004
9	pasireotideIBA 02/2020 - 03/2012
8	GlucocorticoidsIBA 01/2021 - 05/2006
7	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2021 - 03/2012
5	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 06/2013
4	Pharmaceutical PreparationsIBA 01/2019 - 08/2010
4	Glucose (Dextrose)FDA LinkGeneric 01/2016 - 06/2008
4	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2015 - 04/2005
3	OsilodrostatIBA 01/2022 - 01/2020
3	Hormones (Hormone)IBA 01/2022 - 08/2016
2	Ketoconazole (Nizoral)FDA LinkGeneric 01/2021 - 05/2014
2	Metyrapone FDA Link 01/2021 - 11/2015
2	Insulin (Novolin)FDA Link 01/2013 - 01/2010
1	Cinacalcet (Sensipar)FDA Link 01/2022
1	Parathyroid Hormone (Parathormone)IBA 01/2022
1	Growth Hormone (Somatotropin)IBA 10/2021
1	Cytidine Triphosphate (CTP)IBA 03/2021
1	AndrogensIBA 01/2021
1	Mixed Function Oxygenases (Monooxygenases)IBA 01/2020
1	Dihydrotachysterol (AT 10)IBA 01/2020
1	Steroid 11-beta-Hydroxylase (11 beta-Hydroxylase)IBA 01/2020
1	N 30IBA 01/2020
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2019
1	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2019
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2019
1	ErbB Receptors (EGF Receptor)IBA 01/2019
1	Dopamine (Intropin)FDA LinkGeneric 01/2019
1	Cabergoline FDA LinkGeneric 01/2019
1	AldosteroneIBA 12/2018
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 12/2016
1	Biomarkers (Surrogate Marker)IBA 11/2016
1	Codon (Codons)IBA 01/2016
1	Antihypertensive Agents (Antihypertensives)IBA 08/2015
1	Octreotide (Sandostatin)FDA LinkGeneric 01/2015
1	Mineralocorticoid Receptor AntagonistsIBA 02/2014
1	Spironolactone (Aldactone)FDA LinkGeneric 02/2014
1	Eplerenone (Inspra)FDA LinkGeneric 02/2014
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2013
1	Mifepristone (RU 486)FDA Link 01/2013
1	SteroidsIBA 01/2010
1	Dopamine Agonists (Dopamine Agonist)IBA 04/2005
1	amsonic acid (DAS)IBA 04/2005

Therapy/Procedure

10	Therapeutics 01/2021 - 09/2004
6	Radiotherapy 12/2021 - 04/2005
6	Adrenalectomy 03/2021 - 02/2006
2	Drug Therapy (Chemotherapy) 12/2019 - 01/2019
2	Aftercare (After-Treatment) 01/2019 - 01/2018
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 03/2011